Skip to Main Content
Advertisement
Close
AACR Journals
Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics
For Authors
Information for Authors
Author Services
Journal Awards
Best of: Author Profiles
About Us
AACR Journals
Advertising
Permissions & Reprints
Subscriptions
Submit
Article Collections
Journal Collections
Cancer Hallmarks Collection
Hot Topics
'Best Of' Collection
Editors' Picks
COVID-19
Cancer Hallmarks
Webinars
Search Dropdown Menu
header search
search input
Search input auto suggest
Search
Advanced Search
User Tools Dropdown
Register
Sign In
Toggle Menu
Menu
About
The Journal
Editorial Board
AACR Journals
Subscriptions
Permissions and Reprints
Articles
Online First
Issues
CCR Focus Archives
Meeting Abstracts
Collection: Clinical Trials
Collection: Sarcoma
Collection: Lymphoma
Collection: Breast Cancer
Collection: Immunotherapy: Facts and Hopes
Collection: Editors' Picks
COVID-19
Collection: 'Best 'Of' Collection
For Authors
Information for Authors
Author Services
Best of: Author Profiles
Submit
Alerts
News
Cancer Hallmarks
Webinars
Skip Nav Destination
Issues
Select Year
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
Issue
1 January - Volume 28, Issue 1, Pages 1 - 245
15 January - Volume 28, Issue 2, Pages 247 - 431
1 February - Volume 28, Issue 3, Pages 433 - 567
15 February - Volume 28, Issue 4, Pages 569 - 809
1 March - Volume 28, Issue 5, Pages 811 - 1052
15 March - Volume 28, Issue 6, Pages 1053 - 1239
1 April - Volume 28, Issue 7, Pages 1241 - 1473
15 April - Volume 28, Issue 8, Pages 1475 - 1741
1 May - Volume 28, Issue 9, Pages 1743 - 1990
15 May - Volume 28, Issue 10, Pages 1991 - 2197
1 June - Volume 28, Issue 11, Pages 2199 - 2473
15 June - Volume 28, Issue 12, Pages 2475 - 2715
1 July - Volume 28, Issue 13, Pages 2717 - 2973
15 July - Volume 28, Issue 14, Pages 2975 - 3169
1 August - Volume 28, Issue 15, Pages 3171 - 3401
15 August - Volume 28, Issue 16, Pages 3403 - 3629
1 September - Volume 28, Issue 17, Pages 3631 - 3901
1 September - Volume 28, Issue 17_Supplement
15 September - Volume 28, Issue 18, Pages 3903 - 4158
15 September - Volume 28, Issue 18_Supplement
1 October - Volume 28, Issue 19, Pages 4159 - 4353
15 October - Volume 28, Issue 20, Pages 4355 - 4589
1 November - Volume 28, Issue 21, Pages 4591 - 4831
15 November - Volume 28, Issue 22, Pages 4833 - 5003
1 December - Volume 28, Issue 23, Pages 5005 - 5230
15 December - Volume 28, Issue 24, Pages 5231 - 5469
Volume 28, Issue 17_Supplement
1 September 2022
ISSN 1078-0432
EISSN 1557-3265
Close navigation menu
In this Issue
Keynote Lecture
Immunotherapies in HCC: Molecular Mechanisms and Combination Regimens
Inflammation and Liver Cancer
Molecular Pathogenesis and Drivers of Cholangiocarcinoma
Molecular Pathogenesis and Treatment of Hepatoblastoma
Molecular Pathogenesis of Hepatocellular Carcinoma
Molecular Targeted Therapies and Precision Oncology in iCCA
Molecular Targeted Therapies in HCC
Risk Factors, Surveillance, and Molecular Detection
Trial Design and Endpoints in HCC
Other Topics
Issue Navigation
Search within issue:
Search within issue
Abstracts: AACR Special Conference: Advances in the Pathogenesis and Molecular Therapies of Liver Cancer; May 5-8, 2022; Boston, MA
Keynote Lecture
Immunotherapies in HCC: Molecular Mechanisms and Combination Regimens
Inflammation and Liver Cancer
Molecular Pathogenesis and Drivers of Cholangiocarcinoma
Molecular Pathogenesis and Treatment of Hepatoblastoma
Molecular Pathogenesis of Hepatocellular Carcinoma
Molecular Targeted Therapies and Precision Oncology in iCCA
Molecular Targeted Therapies in HCC
Risk Factors, Surveillance, and Molecular Detection
Trial Design and Endpoints in HCC
Other Topics
All Issues
Advertisement
Email alerts
Online First Alert
eTOC Alert
Close Modal
Latest
Most Read
Most Cited
Hyper-Dependence on NHEJ Enables Synergy Between DNA-PK Inhibitors and Low-Dose Doxorubicin in Leiomyosarcoma
Clinical Behavior and Molecular Landscape of Stage I p53-abnormal Low-Grade Endometrioid Endometrial Carcinomas
Olaparib and celarasertib (AZD6738) in patients with triple negative advanced breast cancer: results from Cohort E of the plasmaMATCH trial (CRUK/15/010)
Comparative Genomic Analysis and Clinical Outcomes of BRAF-mutated Advanced Biliary Tract Cancers
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to
our privacy policy.
Accept
